secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTEGRA LIFESCIENCES HOLDINGS CORP (IART)
CIK:        0000917520
Form:       8-K
Filed at:   2023-06-21T23:59:59+00:00
Accession:  0000917520-23-000054
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Integra LifeSciences appoints Lea Daniels Knight as EVP and CFO effective June 28
--------------------------------------------------------------------------------

- Knight brings over 30 years of experience, most recently as EVP Business Finance at Booz Allen Hamilton, and 18 years at Johnson & Johnson.
- Compensation includes $600K base salary, 90% target bonus, $1M RSU grant, $350K cash sign-on, and $1.65M 2024 LTI target.
- Jeff Mosebrook ceases as principal financial officer but remains SVP Finance and principal accounting officer.
- Appointment effective June 28, 2023; Knight succeeds interim CFO role held since February 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/917520/000091752023000054/0000917520-23-000054-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/917520/000091752023000054/iart-20230621.htm
  HTML page:      https://secwatch.observer/filing/0000917520-23-000054

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer